日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy

免疫检查点抑制剂治疗后甲状腺功能监测的充分性

期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP-25-00027
Velez, Maria A; Kang, Elliot S; Thompson, Chester A; Lind-Lebuffe, Jackson; Shen, Collin; Park, Seung Jun; Han, Andy; Gower, Arjan; Li, Daniel; Rochigneux, Philippe; Grogan, Tristan R; Elashoff, David A; Garon, Edward B; Lisberg, Aaron
Checkpoint
免疫/内分泌
发表日期：2026
文献求助 收藏

Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework

影响临床试验吸引力和参与者投资回报的特征：综述与框架

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf313
Fernandez Turizo, Maria J; Velez, Maria A; Glenn, Beth; Cummings, Amy L; Segarra-Vazquez, Barbara; Gorbatov, Sarah; Park, Seung J; Shen, Collin; Lind-Lebuffe, Jackson P; Unger, Joseph M; Garon, Edward B
发表日期：2025
文献求助 收藏

Consent document translation expense hinders inclusive clinical trial enrolment

知情同意书翻译费用阻碍了包容性临床试验的招募

期刊:Nature
影响因子:48.5
doi:10.1038/s41586-023-06382-0
Velez, Maria A; Glenn, Beth A; Garcia-Jimenez, Maria; Cummings, Amy L; Lisberg, Aaron; Nañez, Andrea; Radwan, Yazeed; Lind-Lebuffe, Jackson P; Brodrick, Paige M; Li, Debory Y; Fernandez-Turizo, Maria J; Gower, Arjan; Lindenbaum, Maggie; Hegde, Manavi; Brook, Jenny; Grogan, Tristan; Elashoff, David; Teitell, Michael A; Garon, Edward B
发表日期：2023
文献求助 收藏

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

免疫检查点抑制剂诱发的甲状腺功能障碍是NSCLC治疗后常见的并发症。

期刊:Lung Cancer
影响因子:4.4
doi:10.1016/j.lungcan.2021.08.009
Zhou, Nanruoyi; Velez, Maria A; Bachrach, Benjamin; Gukasyan, Jaklin; Fares, Charlene M; Cummings, Amy L; Lind-Lebuffe, Jackson P; Akingbemi, Wisdom O; Li, Debory Y; Brodrick, Paige M; Yessuf, Nawal M; Rettinger, Sarah; Grogan, Tristan; Rochigneux, Philippe; Goldman, Jonathan W; Garon, Edward B; Lisberg, Aaron
CLC
免疫/内分泌
发表日期：2021
文献求助 收藏